Preliminary studies reveal conolidine might inhibit unique ion channels, minimizing neuronal excitability and limiting discomfort signals. This system is particularly applicable in neuropathic agony, exactly where abnormal signaling causes persistent irritation. Additionally, conolidine seems to impact G protein-coupled receptor (GPCR) pathways int